{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:56:22Z","timestamp":1769306182483,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00105-017-4022-4","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T14:08:35Z","timestamp":1501596515000},"page":"721-726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapie indolenter kutaner B\u2011Zell-Lymphome","Treatment of indolent cutaneous B\u2011cell lymphoma"],"prefix":"10.1007","volume":"68","author":[{"given":"M.","family":"Wobser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"issue":"10","key":"4022_CR1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","volume":"32","author":"G Burg","year":"2005","unstructured":"Burg G, Kempf W, Cozzio A, Feit J, Willemze R, Jaffe SE et\u00a0al (2005) WHO\/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J\u00a0Cutan Pathol 32(10):647\u2013674","journal-title":"J Cutan Pathol"},{"issue":"20","key":"4022_CR2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et\u00a0al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"issue":"12","key":"4022_CR3","first-page":"1207","volume":"14","author":"JP Nicolay","year":"2016","unstructured":"Nicolay JP, Wobser M (2016) B\u2011Zell-Lymphome der Haut \u2013 Pathogenese, Diagnostik und Therapie. J\u00a0Dtsch Dermatol Ges 14(12):1207\u20131225","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"4022_CR4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2340\/00015555-1112","volume":"91","author":"C Hallermann","year":"2011","unstructured":"Hallermann C, Niermann C, Fischer R\u2011J, Schulze H\u2011J (2011) Survival data for 299 patients with primary cutaneous lymphomas: a\u00a0monocentre study. Acta Derm Venereol 91(5):521\u2013525","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"4022_CR5","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","volume":"25","author":"NJ Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Jansen PM, Vermeer MH, van Baarlen J, Blokx WA et al (2007) Reclassification of 300 primary cutaneous B\u2011Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J\u00a0Clin Oncol 25(12):1581\u20131587","journal-title":"J Clin Oncol"},{"issue":"8","key":"4022_CR6","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","volume":"107","author":"F Suarez","year":"2006","unstructured":"Suarez F, Lortholary O, Hermine O, Lecuit M (2006) Infection-associated lymphomas derived from marginal zone B cells: a\u00a0model of antigen-driven lymphoproliferation. Blood 107(8):3034\u20133044","journal-title":"Blood"},{"issue":"8","key":"4022_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0560.1997.tb01318.x","volume":"24","author":"L Cerroni","year":"1997","unstructured":"Cerroni L, Z\u00f6chling N, P\u00fctz B, Kerl H (1997) Infection by Borrelia burgdorferi and cutaneous B\u2011cell lymphoma. J\u00a0Cutan Pathol 24(8):457\u2013461","journal-title":"J Cutan Pathol"},{"issue":"6","key":"4022_CR8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11864-015-0344-6","volume":"16","author":"LH Foster","year":"2015","unstructured":"Foster LH, Portell CA (2015) The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas. Curr Treat Options Oncol 16(6):28","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"4022_CR9","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1634\/theoncologist.2011-0108","volume":"16","author":"M Ponzoni","year":"2011","unstructured":"Ponzoni M, Ferreri AJM, Mappa S, Pasini E, Govi S, Facchetti F et\u00a0al (2011) Prevalence of Borrelia burgdorferi infection in a\u00a0series of 98 primary cutaneous lymphomas. Oncologist 16(11):1582\u20131588","journal-title":"Oncologist"},{"issue":"6","key":"4022_CR10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1034\/j.1600-0560.2003.00083.x","volume":"30","author":"S Michaelis","year":"2003","unstructured":"Michaelis S, Kazakov DV, Schmid M, Dummer R, Burg G, Kempf W (2003) Hepatitis C and G viruses in B\u2011cell lymphomas of the skin. J\u00a0Cutan Pathol 30(6):369\u2013372","journal-title":"J Cutan Pathol"},{"issue":"3","key":"4022_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/DAD.0b013e31804795a6","volume":"29","author":"G Palmedo","year":"2007","unstructured":"Palmedo G, Hantschke M, R\u00fctten A, Mentzel T, Kempf W, Tomasini D et al (2007) Primary cutaneous marginal zone B\u2011cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH\/BCL2 and the t(14;18)(q32;q21) IGH\/MALT1 translocation: an indicator for clonal transformation towards higher-grade B\u2011cell lymphoma? Am J Dermatopathol 29(3):231\u2013236","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"4022_CR12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/jid.2008.243","volume":"129","author":"AJA Deutsch","year":"2009","unstructured":"Deutsch AJA, Fr\u00fchwirth M, Aigelsreiter A, Cerroni L, Neumeister P (2009) Primary cutaneous marginal zone B\u2011cell lymphomas are targeted by aberrant somatic hypermutation. J\u00a0Invest Dermatol 129(2):476\u2013479","journal-title":"J Invest Dermatol"},{"key":"4022_CR13","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/bjd.13960","volume":"173","author":"I Brenner","year":"2015","unstructured":"Brenner I, Roth S, Flossbach L, Wobser M, Rosenwald A, Geissinger E (2015) Lack of MYD88 L265P mutation in primary cutaneous marginal zone lymphoma. Br J Dermatol 2015 Dec;173(6):1527\u20131528. doi: 10.1111\/bjd.13960","journal-title":"Br J Dermatol"},{"key":"4022_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15183","author":"M Wobser","year":"2016","unstructured":"Wobser M, Maurus K, Roth S, Appenzeller S, Weyandt G, Goebeler M et al (2016) MYD88 mutations in a\u00a0distinct type of cutaneous marginal zone lymphoma with a\u00a0non-class switched IgM-immunophenotype. Br J Dermatol. doi: 10.1111\/bjd.15183","journal-title":"Br J Dermatol"},{"issue":"1","key":"4022_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1309\/AJCPW64FFBTTPKFN","volume":"133","author":"JT Geyer","year":"2010","unstructured":"Geyer JT, Ferry JA, Longtine JA, Flotte TJ, Harris NL, Zukerberg LR (2010) Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a\u00a0T cell-rich background. Am J Clin Pathol 133(1):59\u201369","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"4022_CR16","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","volume":"34","author":"JT Edinger","year":"2010","unstructured":"Edinger JT, Kant JA, Swerdlow SH (2010) Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets. Am J Surg Pathol 34(12):1830\u20131841","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4022_CR17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"YH Kim","year":"2007","unstructured":"Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A et\u00a0al (2007) TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a\u00a0proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110(2):479\u2013484","journal-title":"Blood"},{"issue":"9","key":"4022_CR18","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","volume":"24","author":"PL Zinzani","year":"2006","unstructured":"Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S et al (2006) Prognostic factors in primary cutaneous B\u2011cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J\u00a0Clin Oncol Off J Am Soc Clin Oncol 24(9):1376\u20131382","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"4022_CR19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1365-2133.2002.04961.x","volume":"147","author":"O Servitje","year":"2002","unstructured":"Servitje O, Gallardo F, Estrach T, Pujol RM, Blanco A, Fern\u00e1ndez-Sevilla A et al (2002) Primary cutaneous marginal zone B\u2011cell lymphoma: a\u00a0clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol 147(6):1147\u20131158","journal-title":"Br J Dermatol"},{"issue":"12","key":"4022_CR20","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","volume":"26","author":"I Brenner","year":"2013","unstructured":"Brenner I, Roth S, Puppe B, Wobser M, Rosenwald A, Geissinger E (2013) Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression. Mod Pathol 26(12):1568\u20131576","journal-title":"Mod Pathol"},{"issue":"3","key":"4022_CR21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DAD.0b013e318289b20e","volume":"36","author":"W Kempf","year":"2014","unstructured":"Kempf W, Kazakov DV, Mitteldorf C (2014) Cutaneous lymphomas: an update. Part 2: B\u2011cell lymphomas and related conditions. Am J Dermatopathol 36(3):197\u2013208-210","journal-title":"Am J Dermatopathol"},{"issue":"12","key":"4022_CR22","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","volume":"33","author":"JT Edinger","year":"2009","unstructured":"Edinger JT, Clark BZ, Pucevich BE, Geskin LJ, Swerdlow SH (2009) CD30 expression and proliferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol 33(12):1860\u20131868","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4022_CR23","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","volume":"112","author":"NJ Senff","year":"2008","unstructured":"Senff NJ, Noordijk EM, Kim YH, Bagot M, Berti E, Cerroni L et al (2008) European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B\u2011cell lymphomas. Blood 112(5):1600\u20131609","journal-title":"Blood"},{"issue":"3","key":"4022_CR24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1684\/ejd.2009.0633","volume":"19","author":"G Quereux","year":"2009","unstructured":"Quereux G, Frot AS, Brocard A, Leux C, Renaut J\u2011J, Dreno B (2009) Routine bone marrow biopsy in the initial evaluation of primary cutaneous B\u2011cell lymphoma does not appear justified. Eur J Dermatol 19(3):216\u2013220","journal-title":"Eur J Dermatol"},{"issue":"2","key":"4022_CR25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2008.08659.x","volume":"159","author":"E Bathelier","year":"2008","unstructured":"Bathelier E, Thomas L, Balme B, Coiffier B, Salles G, Berger F et al (2008) Asymptomatic bone marrow involvement in patients presenting with cutaneous marginal zone B\u2011cell lymphoma. Br J Dermatol 159(2):498\u2013500","journal-title":"Br J Dermatol"},{"issue":"1","key":"4022_CR26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2141.2008.07159.x","volume":"142","author":"NJ Senff","year":"2008","unstructured":"Senff NJ, Kluin-Nelemans HC, Willemze R (2008) Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B\u2011cell lymphoma. Br J Haematol 142(1):52\u201356","journal-title":"Br J Haematol"},{"issue":"12","key":"4022_CR27","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","volume":"143","author":"NJ Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Neelis KJ, Vermeer MH, Noordijk EM, Willemze R et al (2007) Results of radiotherapy in 153 primary cutaneous B\u2011Cell lymphomas classified according to the WHO-EORTC classification. Arch Dermatol 143(12):1520\u20131526","journal-title":"Arch Dermatol"},{"issue":"4","key":"4022_CR28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","volume":"55","author":"HT Eich","year":"2003","unstructured":"Eich HT, Eich D, Micke O, S\u00fcttzer H, Casper C, Krieg T et al (2003) Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B\u2011cell lymphoma. Int J Radiat Oncol Biol Phys 55(4):899\u2013906","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4022_CR29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","volume":"92","author":"L Specht","year":"2015","unstructured":"Specht L, Dabaja B, Illidge T, Wilson LD, Hoppe RT, International Lymphoma Radiation Oncology Group (2015) Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92(1):32\u201339","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4022_CR30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2013.11.019","volume":"70","author":"S Vandersee","year":"2014","unstructured":"Vandersee S, Terhorst D, Humme D, Beyer M (2014) Treatment of indolent primary cutaneous B\u2011cell lymphomas with subcutaneous interferon-alfa. J\u00a0Am Acad Dermatol 70(4):709\u2013715","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4022_CR31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2133.2012.10902.x","volume":"167","author":"Y Pe\u00f1ate","year":"2012","unstructured":"Pe\u00f1ate Y, Hern\u00e1ndez-Mach\u00edn B, P\u00e9rez-M\u00e9ndez LI, Santiago F, Rosales B, Servitje O et al (2012) Intralesional rituximab in the treatment of indolent primary cutaneous B\u2011cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma. Br J Dermatol 167(1):174\u2013179","journal-title":"Br J Dermatol"},{"issue":"3","key":"4022_CR32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2133.2005.06433.x","volume":"152","author":"AM Roguedas","year":"2005","unstructured":"Roguedas AM, Watier H, Paintaud G, de Muret A, Vaillant L, Machet L (2005) Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B\u2011cell lymphoma. Br J Dermatol 152(3):541\u2013544","journal-title":"Br J Dermatol"},{"issue":"9","key":"4022_CR33","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1080\/10428190802258923","volume":"49","author":"S Maza","year":"2008","unstructured":"Maza S, Gellrich S, Assaf C, Beyer M, Spilker L, Orawa H et al (2008) Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B\u2011cell lymphomas: first results of a\u00a0prospective, monocentre study. Leuk Lymphoma 49(9):1702\u20131709","journal-title":"Leuk Lymphoma"},{"key":"4022_CR34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1749-6632.2012.06661.x","volume":"1263","author":"IV Gupta","year":"2012","unstructured":"Gupta IV, Jewell RC (2012) Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies. Ann N Y Acad Sci 1263:43\u201356","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"4022_CR35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/bjh.13764","volume":"171","author":"A Awasthi","year":"2015","unstructured":"Awasthi A, Ayello J, Van de Ven C, Elmacken M, Sabulski A, Barth MJ (2015) Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive\/-resistant Burkitt lymphoma (BL) and precursor B\u2011acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20(+) BL and pre-B-ALL. Br J Haematol 171(5):763\u2013775","journal-title":"Br J Haematol"},{"issue":"5","key":"4022_CR36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/bjd.12484","volume":"169","author":"A Brandenburg","year":"2013","unstructured":"Brandenburg A, Humme D, Terhorst D, Gellrich S, Sterry W, Beyer M (2013) Long-term outcome of intravenous therapy with rituximab in patients with primary cutaneous B\u2011cell lymphomas. Br J Dermatol 169(5):1126\u20131132","journal-title":"Br J Dermatol"},{"issue":"4","key":"4022_CR37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2133.2001.04128.x","volume":"144","author":"FJ Child","year":"2001","unstructured":"Child FJ, Russell-Jones R, Woolford AJ, Calonje E, Photiou A, Orchard G et al (2001) Absence of the t(14;18) chromosomal translocation in primary cutaneous B\u2011cell lymphoma. Br J Dermatol 144(4):735\u2013744","journal-title":"Br J Dermatol"},{"key":"4022_CR38","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","volume":"136","author":"S Menguy","year":"2016","unstructured":"Menguy S, Gros A, Pham-Ledard A, Battistella M, Ortonne N, Comoz F et al (2016) MYD88 somatic mutation is a\u00a0diagnostic criterion in primary cutaneous large B\u2011cell lymphoma. J\u00a0Invest Dermatol 2016 Aug 136(8):1741\u20131744. doi: 10.1016\/j.jid.2016.04.018","journal-title":"J Invest Dermatol"},{"issue":"11","key":"4022_CR39","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2014.821","volume":"150","author":"A Pham-Ledard","year":"2014","unstructured":"Pham-Ledard A, Beylot-Barry M, Barbe C, Leduc M, Petrella T, Vergier B et al (2014) High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B\u2011cell lymphoma, leg-type. JAMA Dermatol 150(11):1173\u20131179","journal-title":"JAMA Dermatol"},{"issue":"9","key":"4022_CR40","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","volume":"105","author":"JJ Hoefnagel","year":"2005","unstructured":"Hoefnagel JJ, Dijkman R, Basso K, Jansen PM, Hallermann C, Willemze R et al (2005) Distinct types of primary cutaneous large B\u2011cell lymphoma identified by gene expression profiling. Blood 105(9):3671\u20133678","journal-title":"Blood"},{"issue":"6769","key":"4022_CR41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al (2000) Distinct types of diffuse large B\u2011cell lymphoma identified by gene expression profiling. Nature 403(6769):503\u2013511","journal-title":"Nature"},{"issue":"3","key":"4022_CR42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2133.2009.09576.x","volume":"162","author":"M Perez","year":"2010","unstructured":"Perez M, Pacchiarotti A, Frontani M, Pescarmona E, Caprini E, Lombardo GA et al (2010) Primary cutaneous B\u2011cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments. Br J Dermatol 162(3):611\u2013618","journal-title":"Br J Dermatol"},{"issue":"1","key":"4022_CR43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00292-006-0881-7","volume":"28","author":"E Geissinger","year":"2007","unstructured":"Geissinger E, Adam P, M\u00fcller-Hermelink HK, R\u00fcdiger T (2007) Cutaneous B\u2011cell lymphoma. Classification and diagnostics. Pathologe 28(1):15\u201320","journal-title":"Pathologe"},{"issue":"1","key":"4022_CR44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al (2004) Confirmation of the molecular classification of diffuse large B\u2011cell lymphoma by immunohistochemistry using a\u00a0tissue microarray. Blood 103(1):275\u2013282","journal-title":"Blood"},{"issue":"4","key":"4022_CR45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/jnci\/djn478","volume":"101","author":"L Vidal","year":"2009","unstructured":"Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz S\u2011F et al (2009) Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J\u00a0Natl Cancer Inst 101(4):248\u2013255","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"4022_CR46","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archdermatol.2009.280","volume":"145","author":"MF Benner","year":"2009","unstructured":"Benner MF, Willemze R (2009) Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma. Arch Dermatol 145(12):1399\u20131404","journal-title":"Arch Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-4022-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4022-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4022-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:16:26Z","timestamp":1602634586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-4022-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["4022"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-4022-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}